Literature DB >> 18605971

Pregnancy outcome of women who developed proteinuria in the absence of hypertension after mid-gestation.

Mamoru Morikawa1, Takashi Yamada, Takahiro Yamada, Kazutoshi Cho, Hideto Yamada, Noriaki Sakuragi, Hisanori Minakami.   

Abstract

OBJECTIVE: To characterize the clinical features of women with singleton pregnancies who develop proteinuria in the absence of hypertension after mid-gestation.
METHODS: Seventy-nine women who developed proteinuria and/or hypertension at and after 20 weeks of gestation were reviewed, focusing on the gestational week at which significant proteinuria (>0.3 g/day) and/or hypertension developed.
RESULTS: Thirty-seven (47%) women exhibited new-onset proteinuria (>0.3 g/day) in the absence of hypertension, 33 (42%) exhibited new-onset hypertension in the absence of proteinuria, and 9 (11%) exhibited both proteinuria and hypertension. Nineteen (51%) of 37 women who exhibited new proteinuria in the absence of hypertension and 5 (15%) of 33 women who exhibited new hypertension in the absence of proteinuria progressed to preeclampsia (P=0.002). Among women who exhibited new proteinuria, 10 (77%) out of 13 women and 9 (38%) out of 24 women who developed proteinuria at <32 weeks and >or=32 weeks, respectively, progressed to preeclampsia (P=0.022).
CONCLUSIONS: Women with new-onset proteinuria in the absence of hypertension may be more likely to progress to preeclampsia than women with a presumptive diagnosis of gestational hypertension, and the likelihood of progression may be significantly greater among women with earlier presentation.

Entities:  

Mesh:

Year:  2008        PMID: 18605971     DOI: 10.1515/JPM.2008.062

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  8 in total

1.  Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria.

Authors:  S Shinar; J Asher-Landsberg; A Schwartz; M Ram-Weiner; M J Kupferminc; A Many
Journal:  J Perinatol       Date:  2015-10-29       Impact factor: 2.521

2.  Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?

Authors:  Takako Ohmaru; Akihide Ohkuchi; Shigeaki Muto; Chikako Hirashima; Shigeki Matsubara; Mitsuaki Suzuki
Journal:  CEN Case Rep       Date:  2013-08-23

3.  The risk factors for labor onset hypertension.

Authors:  Yasumasa Ohno; Mikio Terauchi; Koji Tamakoshi; Arihiro Shiozaki; Shigeru Saito
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

4.  Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef M Cortez; Athina Pappas; Adi L Tarca; Piya Chaemsaithong; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-08

5.  Feasibility of nephrinuria as a screening tool for the risk of pre-eclampsia: prospective observational study.

Authors:  Tianyue Zhai; Itsuko Furuta; Rina Akaishi; Kosuke Kawabata; Kentaro Chiba; Takeshi Umazume; Satoshi Ishikawa; Takahiro Yamada; Mamoru Morikawa; Hisanori Minakami
Journal:  BMJ Open       Date:  2016-08-02       Impact factor: 2.692

Review 6.  Current best practice in the management of hypertensive disorders in pregnancy.

Authors:  Rosemary Townsend; Patrick O'Brien; Asma Khalil
Journal:  Integr Blood Press Control       Date:  2016-07-27

7.  High-risk factors for adverse pregnancy outcomes in systemic lupus erythaematosus: a retrospective study of a Chinese population.

Authors:  Meng Jiang; Yanling Chang; You Wang; Qiong Fu; Sihan Lin; Jiayue Wu; Wen Di
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

8.  Clinical features of isolated gestational proteinuria progressing to pre-eclampsia: retrospective observational study.

Authors:  Rina Akaishi; Takahiro Yamada; Mamoru Morikawa; Ryutaro Nishida; Hisanori Minakami
Journal:  BMJ Open       Date:  2014-04-19       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.